These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7714188)

  • 1. Proposed quality control guidelines for antimicrobial susceptibility tests using tilmicosin.
    Shryock TR; White DW; Werner CS; Staples JM
    J Clin Microbiol; 1995 Feb; 33(2):331-5. PubMed ID: 7714188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella spp. associated with bovine respiratory disease.
    Shryock TR; White DW; Staples JM; Werner CS
    J Vet Diagn Invest; 1996 Jul; 8(3):337-44. PubMed ID: 8844577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro antibacterial properties of tilmicosin against Australian isolates of Pasteurella multocida and Pasteurella haemolytica from cattle.
    Stephens CP; Blackall PJ; Wade LK; Lowe LB
    Aust Vet J; 1993 Oct; 70(10):391-2. PubMed ID: 8257321
    [No Abstract]   [Full Text] [Related]  

  • 4. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella multocida and Actinobacillus pleuropneumoniae associated with porcine respiratory disease.
    Shryock TR; Staples JM; DeRosa DC
    J Vet Diagn Invest; 2002 Sep; 14(5):389-95. PubMed ID: 12296390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of in vitro minimum inhibitory concentrations of tilmicosin against Mannheimia haemolytica and Pasteurella multocida and in vivo tilmicosin treatment outcome among calves with signs of bovine respiratory disease.
    McClary DG; Loneragan GH; Shryock TR; Carter BL; Guthrie CA; Corbin MJ; Mechor GD
    J Am Vet Med Assoc; 2011 Jul; 239(1):129-35. PubMed ID: 21718206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of porcine respiratory pathogens to tilmicosin.
    DeRosa DC; Veenhuizen MF; Bade DJ; Shryock TR
    J Vet Diagn Invest; 2000 Nov; 12(6):541-6. PubMed ID: 11108454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between the minimal inhibitory concentration of tilmicosin and oxytetracycline for bovine pneumonic Pasteurella haemolytica isolates.
    Hartman EG; Geryl J
    Vet Q; 1993 Dec; 15(4):184. PubMed ID: 8122359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality control guidelines for disk diffusion and broth microdilution antimicrobial susceptibility tests with seven drugs for veterinary applications.
    Odland BA; Erwin ME; Jones RN
    J Clin Microbiol; 2000 Jan; 38(1):453-5. PubMed ID: 10618141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 4-year survey of antimicrobial susceptibility trends for isolates from cattle with bovine respiratory disease in North America.
    Watts JL; Yancey RJ; Salmon SA; Case CA
    J Clin Microbiol; 1994 Mar; 32(3):725-31. PubMed ID: 8195385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Resistance pattern of bovine Pasteurella].
    Hörmansdorfer S; Bauer J
    Berl Munch Tierarztl Wochenschr; 1996 May; 109(5):168-71. PubMed ID: 8694744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment history and antimicrobial susceptibility results for Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni isolates from bovine respiratory disease cases submitted to the Iowa State University Veterinary Diagnostic Laboratory from 2013 to 2015.
    Magstadt DR; Schuler AM; Coetzee JF; Krull AC; O'Connor AM; Cooper VL; Engelken TJ
    J Vet Diagn Invest; 2018 Jan; 30(1):99-104. PubMed ID: 29034785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the toxicology of the antibiotic MICOTIL 300.
    Jordan WH; Byrd RA; Cochrane RL; Hanasono GK; Hoyt JA; Main BW; Meyerhoff RD; Sarazan RD
    Vet Hum Toxicol; 1993 Apr; 35(2):151-8. PubMed ID: 8470360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility patterns of respiratory tract pathogens from sheep and goats.
    Berge AC; Sischo WM; Craigmill AL
    J Am Vet Med Assoc; 2006 Oct; 229(8):1279-81. PubMed ID: 17042733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of spectinomycin and comparator agents against Pasteurella multocida and Mannheimia haemolytica from respiratory tract infections of cattle.
    Schwarz S; Kehrenberg C; Salmon SA; Watts JL
    J Antimicrob Chemother; 2004 Feb; 53(2):379-82. PubMed ID: 14729757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardization of broth microdilution and disk diffusion susceptibility tests for Actinobacillus pleuropneumoniae and Haemophilus somnus: quality control standards for ceftiofur, enrofloxacin, florfenicol, gentamicin, penicillin, tetracycline, tilmicosin, and trimethoprim-sulfamethoxazole.
    McDermott PF; Barry AL; Jones RN; Stein GE; Thornsberry C; Wu CC; Walker RD
    J Clin Microbiol; 2001 Dec; 39(12):4283-7. PubMed ID: 11724833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory benefits of tilmicosin in calves with Pasteurella haemolytica-infected lungs.
    Chin AC; Morck DW; Merrill JK; Ceri H; Olson ME; Read RR; Dick P; Buret AG
    Am J Vet Res; 1998 Jun; 59(6):765-71. PubMed ID: 9622749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased MICs of gamithromycin and tildipirosin in the presence of the genes erm(42) and msr(E)-mph(E) for bovine Pasteurella multocida and Mannheimia haemolytica.
    Michael GB; Eidam C; Kadlec K; Meyer K; Sweeney MT; Murray RW; Watts JL; Schwarz S
    J Antimicrob Chemother; 2012 Jun; 67(6):1555-7. PubMed ID: 22398653
    [No Abstract]   [Full Text] [Related]  

  • 18. In-vitro antibacterial properties of tilmicosin against Australian isolates of Pasteurella multocida and Actinobacillus pleuropneumoniae from pigs.
    Blackall PJ; Asakawa T; Graydon RJ; White M; Adamson M; Wade LK; Lowe LB
    Aust Vet J; 1995 Jan; 72(1):35-6. PubMed ID: 8787526
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of standardised versus non-standardised methods for testing the in vitro potency of oxytetracycline against Mannheimia haemolytica and Pasteurella multocida.
    Lees P; Illambas J; Pelligand L; Toutain PL
    Vet J; 2016 Dec; 218():60-64. PubMed ID: 27938710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tilmicosin does not inhibit interleukin-8 gene expression in the bovine lung experimentally infected with Mannheimia (Pasteurella) haemolytica.
    Goubau S; Morck DW; Buret A
    Can J Vet Res; 2000 Oct; 64(4):238-42. PubMed ID: 11041503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.